Trial
NCT03949842
Legend: TRELEGY Real World Chronic Obstructive Pulmonary Disease (COPD) Effectiveness Study
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
GlaxoSmithKline
Collaborators
—
Condition
Pulmonary Disease, Chronic Obstructive
Intervention
Inhaled corticosteroids/long-acting beta2-adrenergic/long-acting muscarinic receptor antagonists
Why stopped
The decision to end the study was based on a change in GSK strategy. No subjects were enrolled into the study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-04-22